Altitude Crest Partners »

Apellis Pharmaceuticals shares owned by Altitude Crest Partners

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Altitude Crest Partners from 13F filings

Historical chart of Altitude Crest Partners investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Altitude Crest Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Altitude Crest Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $9.1M 152k 59.86